{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:56:49Z","timestamp":1787003809478,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2003,4,1]]},"DOI":"10.1038\/sj.bmt.1703888","type":"journal-article","created":{"date-parts":[[2003,4,11]],"date-time":"2003-04-11T11:28:15Z","timestamp":1050060495000},"page":"565-569","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Factors associated with survival in patients with progressive disease following autologous transplant for lymphoma"],"prefix":"10.1038","volume":"31","author":[{"given":"O","family":"Paltiel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Rubinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Or","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Nagler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Deutsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Polliack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Naparstek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,4,11]]},"reference":[{"key":"BF1703888_CR1","first-page":"82","volume":"21","author":"JO Armitage","year":"1994","unstructured":"Armitage JO, Vose JM, Bierman PH et al. Salvage therapy for patients with lymphoma. Semin Oncol 1994; 21: 82\u201385.","journal-title":"Semin Oncol"},{"key":"BF1703888_CR2","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","volume":"333","author":"T Philip","year":"1995","unstructured":"Philip T, Guglielmi C, Hagenbeek A et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 1995; 333: 1540\u20131545.","journal-title":"N Engl J Med"},{"key":"BF1703888_CR3","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/0140-6736(93)92411-L","volume":"341","author":"DC Linch","year":"1993","unstructured":"Linch DC, Winfield D, Goldstone AH et al. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial. Lancet 1993; 341: 1051\u20131054.","journal-title":"Lancet"},{"key":"BF1703888_CR4","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1016\/S0140-6736(02)08938-9","volume":"359(9323)","author":"N Schmitz","year":"2002","unstructured":"Schmitz N, Pfistner B, Sextro M et al. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial. Lancet 2002 Jun 15; 359(9323): 2065\u20132071.","journal-title":"Lancet"},{"key":"BF1703888_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1046\/j.1365-2257.2000.00270.x","volume":"22","author":"SJ Simnett","year":"2000","unstructured":"Simnett SJ, Stewart LA, Sweetenham J et al. Autologous stem cell transplantation for malignancy: a systematic review of the literature. Clin Lab Haematol 2000; 22: 61\u201372.","journal-title":"Clin Lab Haematol"},{"key":"BF1703888_CR6","unstructured":"Negrin RS . Prevention and therapy of relapse after autologous hematopoietic cell transplantation. In: Thomas DE, Blume KG, Forman SJ, (eds) Hematopoietic Cell Transplantation, 2nd edn, 1999, pp 1123\u20131133."},{"key":"BF1703888_CR7","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"E Kaplan","year":"1958","unstructured":"Kaplan E, Meier P . Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457\u2013481.","journal-title":"J Am Stat Assoc"},{"key":"BF1703888_CR8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR . Regression model and life tables (with discussion). J R Stat Soc 1972; 34: 187\u2013220.","journal-title":"J R Stat Soc"},{"key":"BF1703888_CR9","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/00002371-199811000-00007","volume":"21","author":"R Or","year":"1998","unstructured":"Or R, Ackerstein A, Nagler A et al. Allogeneic cell-mediated and cytokine-activated immunotherapy for malignant lymphoma at the stage of minimal residual disease after autologous stem cell transplantation. J Immunother 1998; 21: 447\u2013453.","journal-title":"J Immunother"},{"key":"BF1703888_CR10","doi-asserted-by":"crossref","unstructured":"National Cancer Institute sponsored study of classifications non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 1982; 49: 2112\u20132135.","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2"},{"key":"BF1703888_CR11","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood.V89.11.3951","volume":"89","author":"A Nagler","year":"1997","unstructured":"Nagler A, Ackerstein A, Or R et al. Immunotherapy with recombinant human interleukin-2 and recombinant interferon-\u03b1 in lymphoma patients post autologous marrow or stem cell transplantation. Blood 1997; 89: 3951\u20133959.","journal-title":"Blood"},{"key":"BF1703888_CR12","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/S0301-472X(00)00511-7","volume":"28","author":"A Nagler","year":"2000","unstructured":"Nagler A, Or R, Naparstek E et al. Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation. Exp Hematol 2000; 28: 1096\u20131104.","journal-title":"Exp Hematol"},{"key":"BF1703888_CR13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/sj.bmt.1700678","volume":"19","author":"B Bolwell","year":"1997","unstructured":"Bolwell B, Goormastic M, Andresen S . Durability of remission after ABMT for NHL: the importance of the 2-year evaluation point. Bone Marrow Transplantation 1997; 19: 443\u2013448.","journal-title":"Bone Marrow Transplantation"},{"key":"BF1703888_CR14","doi-asserted-by":"crossref","unstructured":"A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factor Project. N Engl J Med 1993; 329: 987\u2013994.","DOI":"10.1056\/NEJM199309303291402"},{"key":"BF1703888_CR15","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1182\/blood.V80.8.2142.2142","volume":"80","author":"JM Vose","year":"1992","unstructured":"Vose JM, Bierman PJ, Anderson JR et al. Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up. Blood 1992; 80: 2142\u20132148.","journal-title":"Blood"},{"key":"BF1703888_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3109\/10428199509054754","volume":"20","author":"M Varterasian","year":"1995","unstructured":"Varterasian M, Ratanatharathorn V, Uberti JP et al. Clinical course and outcome of patients with Hodgkin's disease who progress after autologous transplantation. Leukemia Lymphoma 1995; 20: 59\u201365.","journal-title":"Leukemia Lymphoma"},{"key":"BF1703888_CR17","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/sj.bmt.1700974","volume":"20","author":"BJ Bolwell","year":"1997","unstructured":"Bolwell BJ, Kalaycio M, Goormastic M et al. Progressive disease after ABMT for Hodgkin's disease. Bone Marrow Transplantation 1997; 20: 761\u2013769.","journal-title":"Bone Marrow Transplantation"},{"key":"BF1703888_CR18","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1200\/JCO.1999.17.1.216","volume":"17","author":"J Apostolidis","year":"1999","unstructured":"Apostolidis J, Foran JM, Johnson PWM et al. Patterns of outcome following recurrence after myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma. J Clin Oncol 1999; 17: 216\u2013221.","journal-title":"J Clin Oncol"},{"key":"BF1703888_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1046\/j.1365-2141.1997.3313150.x","volume":"99","author":"MJ Zhang","year":"1997","unstructured":"Zhang MJ, Baccarani M, Gale RP et al. Survival of patients with chronic myelogenous leukaemia relapsing after bone marrow transplantation: comparison with patients receiving conventional chemotherapy. Br J Haematol 1997; 99: 23\u201329.","journal-title":"Br J Haematol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1703888","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703888.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703888.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T02:04:35Z","timestamp":1733969075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1703888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4,1]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,4,1]]}},"alternative-id":["BF1703888"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1703888","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4,1]]},"assertion":[{"value":"27 May 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}